Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy
Learn more about:
Related Clinical Trial
Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
E7 TCR-T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide Excision
Gynaecology Exercise and Mindfulness Study
Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
Retrospective Study of Brachytherapy
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
Serial MRI Scans During Radiation Therapy
A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters for the Treatment of Vulva Cancer
Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients With Vulvar Cancer
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Cisplatin+Pembrolizumab+RT in Vulvar Cancer
Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations
Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer
Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer
Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Validation of a Nutrition Screening Tool
A Survivorship Care Plan for Gynaecological Cancer Patients
Self-Advocacy Serious Game in Advanced Cancer
Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis
MR-HIFU for Recurrent Gynaecological Cancer
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)
A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED)
Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)
Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)
Chemoradiation-Induced Nausea and Emesis: Quality of Life
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)
Longitudinal Evaluation of Women Undergoing Pelvic Exenteration for Treatment of Gynecologic Malignancy
Phase I Study of Intravenous Triapine (IND # 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies
ChemoFx® PRO – A Post-Market Data Collection Study
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Colposcopy and High Resolution Anoscopy in Screening For Anal Dysplasia in Patients With Cervical, Vaginal, or Vulvar Dysplasia or Cancer
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
The Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology Study
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Image-Guided Gynecologic Brachytherapy
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
Topical Imiquimod in Treating Patients With Recurrent Paget’s Disease of the Vulva
Antineoplaston Therapy in Treating Patients With Stage IV Cancer of the Cervix and/or Vulva
Chemoprevention of Cancer in the Lower Female Genital Tract: The Antineoplastic Activity of the Fungicide Ciclopirox.
The Impact of the “WOMAN-PRO II Program” on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence
CaptHPV : Validation of the Method “CaptHPV” for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
Effectiveness of an Individualized Symptom Education Program (ISEP)
A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva
A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer
Radiation Therapy or Surgery in Treating Patients With Previously Untreated Vulva Cancer With Positive Groin Lymph Nodes
Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection
Study to Evaluate the Role of PlasmaJet in Patients Undergoing Groin Node Dissection for Vulval Cancer
Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Cancer of the Vulva
Added-value of SPECT/CT in Patients Undergoing LM/SL for Gynecological Cancers
Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer
OCT-AF Imaging of Pre-cancers of Vulva and Cervix
Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Quality of Life, Unmet Needs and Satisfaction With Care After Vulvar Cancer
Sentinel Node Extended in Squamous Cell Vulvar Cancer
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
Groin Sentinel Node Biopsy and 18FDG-PET/CT in cN0 Vulvar Cancer Patients Candidate to Standard Lymphadenectomy
Ultrasound Morphometric and Cyto/Histological Combined Pre-operative Assessment of Inguinal Lymph Node Status in Women With Invasive Vulvar Carcinoma